As of 2 Nov 2026, Medicamen Organics trades at ₹25.90, close to its 52-week high. The shares fell 22% over the past year.
past year
- ₹25.90
- ₹25.90
- ₹25.90
- ₹25.90
- 12K
Health check
- ReturnsWeak
−22.5% over the past year.
- Price tagn/a
P/E isn’t reported.
- Growthn/a
Not enough yearly results to measure.
- Profitabilityn/a
Return ratios aren’t reported.
- Balance sheetn/a
Balance sheet figures aren’t reported.
- Red flags1 to check
Promoter stake down from 59.7% to 54.9%.
Key metrics
- Market cap
- n/a
- P/E
- n/a
- Price to book
- n/a
- Dividend yield
- n/a
- ROE
- n/a
- Return on equity
- ROCE
- n/a
- Return on capital employed
- Debt to equity
- n/a
- EPS (TTM)
- n/a
- Face value ₹10
- OPM (TTM)
- n/a
- Sales growth
- n/a
- Year-ago quarter not reported
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- n/a
Strengths and risks
Risks to check
- Promoter stake down from 59.7% to 54.9%.
About Medicamen Organics
No company description is available.
- ISIN
- INE0PE401018
Price range
₹25.90₹25.90
₹25.90₹25.90
- Avg volume (3M)
- –
- 1-year return
- minus 22.5%
- From 52-week high
- 0.0%
Peers
We couldn’t find listed peers for this company.
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
This company doesn’t report these figures in a format we can read yet.
Forecast
Balance sheet
This company doesn’t report these figures in a format we can read yet.
Cash flow
This company doesn’t report these figures in a format we can read yet.
Shareholding pattern
54.9%
- Promoters54.89%
- Public45.11%
| Quarter | Split | Promoters | Public | Promoter change |
|---|---|---|---|---|
| 30 Sep 2026 | 54.89% | 45.11% | 0.00 | |
| 9 Jun 2026 | 54.89% | 45.11% | minus 4.84 | |
| 31 Mar 2026 | 59.73% | 40.27% | minus 1.54 | |
| 24 Jan 2026 | 61.27% | 38.73% | plus 1.54 | |
| 30 Sep 2025 | 59.73% | 40.27% | – |
Major shareholders
Filings & events
News
No recent news coverage found.